Cargando…

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?

Heparin is the most commonly prescribed anticoagulant for continuous renal replacement therapy. There is, however, increasing evidence questioning its safety, particularly in the critically ill. Heparin mainly confers its anticoagulant effect by binding to antithrombin. Heparin binds to numerous oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oudemans-van Straaten, Heleen M, Kellum, John A, Bellomo, Rinaldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222015/ https://www.ncbi.nlm.nih.gov/pubmed/21345279 http://dx.doi.org/10.1186/cc9358

Ejemplares similares

Citrate for continuous renal replacement therapy: safer, better and cheaper
por: Oudemans-van Straaten, Heleen M
Publicado: (2014)

Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2012)

Clinical review: Patency of the circuit in continuous renal replacement therapy
por: Joannidis, Michael, et al.
Publicado: (2007)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Citrate anticoagulation for CRRT: don’t always trust the postfilter iCa results!
por: Oudemans-van Straaten, Heleen M., et al.
Publicado: (2015)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
por: Hu, Fang, et al.
Publicado: (2022)

Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis
por: Qi, Wenqian, et al.
Publicado: (2023)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure
por: Rodriguez, Keila, et al.
Publicado: (2017)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Lessons for the clinical nephrologist: vascular access recirculation during continuous renal replacement therapy and regional citrate anticoagulation
por: Scherer, Patricia Faria, et al.
Publicado: (2022)

Regional Citrate Anticoagulation and Systemic Anticoagulation during Pediatric Continuous Renal Replacement Therapy: A Systematic Literature Review
por: Buccione, Emanuele, et al.
Publicado: (2022)

Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
por: Stucker, Fabien, et al.
Publicado: (2015)

Mathematical modelling of post-filter ionized calcium during citrate anticoagulated continuous renal replacement therapy
por: Forsal, Innas, et al.
Publicado: (2021)

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
por: Boer, Willem, et al.
Publicado: (2023)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
por: Honore, Patrick M., et al.
Publicado: (2020)

Citrate dose for continuous hemofiltration: effect on calcium and magnesium balance, parathormone and vitamin D status, a randomized controlled trial
por: Boer, Willem, et al.
Publicado: (2021)

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
por: Liu, Chao, et al.
Publicado: (2016)

Circulating pro-apoptotic mediators in burn septic acute renal failure
por: Oudemans-van Straaten, Heleen M
Publicado: (2008)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
por: Sun, Yuelin, et al.
Publicado: (2023)

How I prescribe continuous renal replacement therapy
por: See, Emily J., et al.
Publicado: (2021)

Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy
por: Bouchard, Josée, et al.
Publicado: (2009)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
por: Klingele, Matthias, et al.
Publicado: (2017)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study
por: Stads, Susanne, et al.
Publicado: (2019)

Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injury
por: Prowle, John R, et al.
Publicado: (2011)

Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients
por: Link, Andreas, et al.
Publicado: (2012)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
por: Davenport, Andrew, et al.
Publicado: (2009)

Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19
por: Khadzhynov, Dmytro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0in8gqq47il1digf5q49gj2s8p